Pancreatic cancer is the fourth leading cause of cancer deaths in the United States each year, in part because around four-fifths of cases go undetected until they have reached an advanced stage. But a new, biomarker-based test could soon change all that — and offer a way to monitor treatment outcomes.

Read/listen to my full story at KJZZ’s Arizona Science Desk:
Biomarker Test Offers Hope For Early Detection Of Pancreatic Cancer